Coloplast Acquires Nine Continents Medical

 Coloplast Acquires Nine Continents Medical

Coloplast Acquires Nine Continents Medical

Shots:

  • Coloplast has acquired implantable tibial nerve stimulation (ITNS) treatment developer Nine Continents Medical for $145M upfront and an additional contingent milestone. ITNS is developed for overactive bladder (OAB)
  • Coloplast expected to initiate clinical studies of ITNS in 2021 with the goal to obtain pre-market approval for a Class III device in the US and EU market approvals in the 2024-2025 timeframe
  • ITNS is a miniaturized, self-powered unit placed in the lower leg in a short, minimally invasive procedure under local anesthesia. The unit does not require patient activation, recharging, or recurring visits to the doctor and works on the clinically proven MoA of percutaneous tibial nerve stimulation

Click here to­ read the full press release/ article | Ref: GlobeNewswire | Image: The Job Network

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post